Cancer Research Annual Meeting 2010  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 3557-3564, September 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schacter, B. A.
Right arrow Articles by Kurz, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schacter, B. A.
Right arrow Articles by Kurz, P.

Alterations in Hepatic and Splenic Microsomal Electron Transport System Components, Drug Metabolism, Heme Oxygenase Activity, and Cytochrome P-450 Turnover in Murphy-Sturm Lymphosarcoma-bearing Rats1

Brent A. Schacter2 and Pat Kurz

Department of Medicine, University of Manitoba, and Manitoba Institute of Cell Biology, 100 Olivia St., Winnipeg, Manitoba, Canada R3E OV9

Hepatic and splenic microsomal electron transport system function, microsomal heme oxygenase activity, and microsomal drug metabolism have been examined in male Wistar rats bearing Murphy-Sturm lymphosarcoma 2 to 15 days following i.m. tumor transplantation. Hepatic microsomal cytochrome P-450 and NADPH-cytochrome c reductase activity decreased significantly [cytochrome P-450 nadir was 0.49 ± .07 (S.E.) nmol/mg at 10 days as compared with 1.21 ± 0.10 for control (p < 0.001); NADPH-cytochrome c reductase nadir was 38.7 ± 3.5 nmol/min/mg at 10 days as compared with 75.3 ± 4.1 for control (p < 0.001)], and hepatic microsomal oxidative drug metabolism was also significantly diminished [benzo-(a)pyrene hydroxylase nadir was 0.35 ± 0.09 nmol/min/mg at 10 days as compared with 1.28 ± 0.36 for control (p < 0.05); aminopyrine demethylase nadir was 0.60 ± 0.27 nmol/hr/mg at 10 days as compared with 2.85 ± 1.40 for control (p < 0.01)]. Conversely, hepatic microsomal heme oxygenase activity was significantly increased (peak was 0.092 ± 0.008 nmol/min/mg at 10 days as compared with 0.038 ± 0.014 for control (p < 0.001)]. Transplantation i.v. or i.p. of Murphy-Sturm lymphosarcoma and transplantation i.m. of Walker 256 carcinosarcoma caused similar alterations in hepatic microsomal function. Splenic microsomal electron transport system function, drug metabolism, and heme oxygenase did not demonstrate these changes, nor could they be wholly reproduced in liver or spleen by transplantation of irradiated tumor cells or 105,000 x g Murphy-Sturm lymphosarcoma cell supernatant. Using double-label isotope techniques, the relative rates of hepatic cytochrome P-450 synthesis and degradation were both found to be significantly decreased in Murphy-Sturm lymphosarcoma-bearing rats as compared with control rats. These results suggest that the capacity for hepatic microsomal oxidative drug metabolism is reduced in Murphy-Sturm lymphosarcoma-bearing rats, due to decreased hepatic microsomal electron transport system function. Hepatic cytochrome P-450 content is reduced, primarily due to decreased cytochrome P-450 synthesis. The resultant increase in size of the hepatic free heme pool may cause substrate-mediated induction of hepatic heme oxygenase in Murphy-Sturm lymphosarcoma-bearing rats.

1 Supported by grants from the Medical Research Council of Canada and the National Cancer Institute of Canada.

2 To whom requests for reprints should be addressed.

Received 12/ 2/81. Accepted 6/ 8/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.